AMWL Share Price | American Well Corp. Stock Analysis & Recommendation

Q: What does American Well Corp. do?

Overview: American Well Corporation is a telehealth company enabling digital delivery of care for the healthcare sector, operating within the Computers - Software & Consulting industry and classified as a micro-cap.Financial Snapshot: Most recent Net Sales: 67 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -18 Million (Quarterly Results - Mar 2025) Market cap: USD 105.77 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.74 Return on Equity: -48.25% Price to Book: 0.36Contact Details: Address: 75 STATE STREET, 26TH FLOOR, BOSTON MA : 02109 Tel: 1 617 2053500 Fax: 1 302 6365454 Website: https://business.amwell.com/

Q: Is American Well Corp. technically bullish or bearish?

As of 10 September 2025, the technical trend for American Well Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the weekly MACD, Bollinger Bands, KST, and moving averages all signaling bearish trends. The Dow Theory also reflects a mildly bearish outlook. The stock has underperformed significantly compared to the S&P 500 across multiple periods, with a 1-year return of -33.37% versus the S&P's 17.14%, and a staggering 5-year return of -98.58% compared to the S&P's 96.61%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

12.44 k

Shareholding (Dec 2025)

FII

10.34%

Held by 57 FIIs

DII

75.78%

Held by 14 DIIs

Promoter

0.53%

How big is American Well Corp.?

22-Jun-2025

As of Jun 18, American Well Corp. has a market capitalization of 105.77 million and reported net sales of 261.68 million with a net loss of 157.55 million over the latest four quarters.

View full answer

What does American Well Corp. do?

22-Jun-2025

American Well Corporation is a telehealth company that provides digital healthcare solutions, with recent net sales of $67 million and a market cap of $105.77 million. It is currently operating at a loss, with a net profit of -$18 million.

View full answer

Who are in the management team of American Well Corp.?

22-Jun-2025

As of March 2022, the management team of American Well Corp. includes Ido Schoenberg as Chairman and CEO, Roy Schoenberg as President and CEO, and Deborah Jackson as an Independent Director.

View full answer

Is American Well Corp. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, American Well Corp. is in a bearish trend with weak strength indicators, having significantly underperformed the S&P 500 with a 1-year return of -33.37% and a 5-year return of -98.58%.

View full answer

Compare American Well Corp. with Similar Stocks

Nextdoor Holdings, Inc.Sharecare, Inc.GoodRx Holdings, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 3.92% of over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

Risky - Negative EBITDA

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Computers - Software & Consulting

Market cap

USD 93 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.76

Return on Equity

-35.56%

Price to Book

0.40

Revenue and Profits:

Net Sales:

55 Million

(Quarterly Results - Dec 2025)

Net Profit:

-25 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

22.66%

6 Months

-10.21%

1 Year

-30.92%

2 Years

-68.05%

3 Years

150.22%

4 Years

-92.37%

5 Years

-98.48%

American Well Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.33%

EBIT Growth (5y)

9.65%

EBIT to Interest (avg)

-222.92

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.74

Sales to Capital Employed (avg)

0.79

Tax Ratio

1.34%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

50.67%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.40

EV to EBIT

0.91

EV to EBITDA

1.45

EV to Capital Employed

-1.50

EV to Sales

-0.34

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-35.56%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 27 Schemes (13.35%)

Foreign Institutions

Held by 57 Foreign Institutions (10.34%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -22.11% vs 0.42% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 43.50% vs 10.80% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "55.30",
          "val2": "71.00",
          "chgp": "-22.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.40",
          "val2": "-30.30",
          "chgp": "52.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "-4.10",
          "chgp": "51.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-25.20",
          "val2": "-44.60",
          "chgp": "43.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-418.50%",
          "val2": "-544.80%",
          "chgp": "12.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -2.00% vs -1.78% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 55.32% vs 68.70% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "249.30",
          "val2": "254.40",
          "chgp": "-2.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-59.10",
          "val2": "-163.20",
          "chgp": "63.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.20",
          "val2": "-20.90",
          "chgp": "46.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-95.00",
          "val2": "-212.60",
          "chgp": "55.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-377.30%",
          "val2": "-773.10%",
          "chgp": "39.58%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

55.30

71.00

-22.11%

Operating Profit (PBDIT) excl Other Income

-14.40

-30.30

52.48%

Interest

0.00

Exceptional Items

-2.00

-4.10

51.22%

Consolidate Net Profit

-25.20

-44.60

43.50%

Operating Profit Margin (Excl OI)

-418.50%

-544.80%

12.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -22.11% vs 0.42% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 43.50% vs 10.80% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

249.30

254.40

-2.00%

Operating Profit (PBDIT) excl Other Income

-59.10

-163.20

63.79%

Interest

0.00

Exceptional Items

-11.20

-20.90

46.41%

Consolidate Net Profit

-95.00

-212.60

55.32%

Operating Profit Margin (Excl OI)

-377.30%

-773.10%

39.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -2.00% vs -1.78% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 55.32% vs 68.70% in Dec 2024

All Annual Results

Company CV

About American Well Corp.

American Well Corp.

Computers - Software & Consulting

American Well Corporation is a telehealth company enabling digital delivery of care for the healthcare sector. The Amwell Platform is a digital care delivery solution that equips its health system and health plan, including government, clients with the tools to enable new models of care for their patients and members. Its technology embeds with its clients’ existing offerings and clinical workflows, spanning the continuum of care and enabling care delivery across a range of clinical, retail, school and home settings. The Amwell Platform consists of the home line, provider-to-patient telehealth interactions, typically in the home, and the hospital line, supporting provider-to-provider telehealth interactions, or provider-to-patient, typically in an inpatient or ambulatory setting. The Company offers a range of management software, clinical workflows, Carepoint hardware and system integrations to deliver care across various modalities, including video, phone and secure messaging.

Company Coordinates

Company Details

75 STATE STREET, 26TH FLOOR , BOSTON MA : 02109

Tel: 1 617 2053500

https://business.amwell.com/

Registrar Details